- Home
- PEPG vs KITT Comparison
PEPG vs KITT Comparison
Compare PEPG & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- KITT
- Stock Information
- Founded
- PEPG 2018
- KITT 2014
- Country
- PEPG United States
- KITT United States
- Employees
- PEPG N/A
- KITT N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- KITT Industrial Machinery/Components
- Sector
- PEPG Health Care
- KITT Industrials
- Exchange
- PEPG Nasdaq
- KITT Nasdaq
- Market Cap
- PEPG 45.5M
- KITT 38.8M
- IPO Year
- PEPG 2022
- KITT N/A
- Fundamental
- Price
- PEPG $1.10
- KITT $0.90
- Analyst Decision
- PEPG Buy
- KITT
- Analyst Count
- PEPG 3
- KITT 0
- Target Price
- PEPG $7.67
- KITT N/A
- AVG Volume (30 Days)
- PEPG 261.3K
- KITT 1.2M
- Earning Date
- PEPG 08-07-2025
- KITT 08-12-2025
- Dividend Yield
- PEPG N/A
- KITT N/A
- EPS Growth
- PEPG N/A
- KITT N/A
- EPS
- PEPG N/A
- KITT N/A
- Revenue
- PEPG N/A
- KITT $1,508,374.00
- Revenue This Year
- PEPG N/A
- KITT $2,936.06
- Revenue Next Year
- PEPG N/A
- KITT N/A
- P/E Ratio
- PEPG N/A
- KITT N/A
- Revenue Growth
- PEPG N/A
- KITT N/A
- 52 Week Low
- PEPG $0.88
- KITT $0.82
- 52 Week High
- PEPG $19.30
- KITT $6.13
- Technical
- Relative Strength Index (RSI)
- PEPG 29.69
- KITT 42.84
- Support Level
- PEPG $1.10
- KITT $0.89
- Resistance Level
- PEPG $1.49
- KITT $0.97
- Average True Range (ATR)
- PEPG 0.10
- KITT 0.06
- MACD
- PEPG -0.04
- KITT -0.01
- Stochastic Oscillator
- PEPG 0.00
- KITT 7.31
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops fully electric autonomous robotic solutions for subsea applications. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing related software to both the commercial and defense business sectors. The company's addressable markets include upstream, midstream, and downstream oil and gas, defense, offshore renewables, seafloor telecommunications, aquaculture, port security, oceanographic research, and subsea mining.